ANP-803

N/A

Report date: 2024/12/03 16:41:11

Base Information

Drug NameANP-803
Drug Alias NameANP-803
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEnvelope glycoprotein inhibitors
TargetsEnvelope glycoprotein
Therapy Area/IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnp Technologies
China Registration ClassN/A

Develop Information

Active CompaniesAnp Technologies
Inactive CompaniesN/A
Active IndicationsMarburg Virus DiseaseHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A